INTLGNT BIO SOL (INBS)
(Delayed Data from NSDQ)
$1.87 USD
-0.01 (-0.53%)
Updated Jul 12, 2024 03:59 PM ET
After-Market: $1.90 +0.03 (1.60%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth D Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
INBS 1.87 -0.01(-0.53%)
Will INBS be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for INBS based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for INBS
Intelligent Bio Solutions Strengthens UK Market Position with Addition of Key Manufacturing Accounts
Intelligent Bio Solutions Completes In-Clinic Portion of Pharmacokinetic (PK) Study Part of 510(k) Pathway for Approval & Commences Review of Results
Intelligent Bio Solutions completes in-clinic portion of PK study
Intelligent Bio Solutions Advances in Regulatory Approval Process
Intelligent Bio Solutions expands presence in the UK retail sector